Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Natco Pharma launches Valsartan Sacubitril tablets in India under brand name VALSAC

      Natco Pharma launches Valsartan Sacubitril tablets in India under brand name VALSAC

      Farhat Nasim31 Jan 2019 10:30 AM IST
      Valsartan Sacubitril is a combination drug used for certain types of heart failure and works by relaxing blood vessels, making it easier for the heart...
      NPPA fixes retail price of 29 drug formulations including BP, Cholesterol, pain medications; Details

      NPPA fixes retail price of 29 drug formulations including BP, Cholesterol, pain medications; Details

      Farhat Nasim30 Jan 2019 11:32 AM IST
      The NPPA order is likely to affect various drug majors including Lupin, Sun Pharmaceuticals, GlaxoSmithKline and Cadila Pharmaceuticals. New Delhi:...
      Incorrect Brand: Chemist slapped of Rs 1.15 lakh for providing alternative to prescribed drug

      Incorrect Brand: Chemist slapped of Rs 1.15 lakh for providing alternative to prescribed drug

      Farhat Nasim29 Jan 2019 3:33 PM IST
      The forum held that they sold different brand than prescribed by the doctor which is indulging in the deficiency in services.Nagpur: Not understanding...
      Cipla gets USFDA nod for Medroxyprogesterone injectable

      Cipla gets USFDA nod for Medroxyprogesterone injectable

      Farhat Nasim29 Jan 2019 11:03 AM IST
      The company has received final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA)...
      DOP directs NPPA to refix the ceiling price of Gentamicin based on Abbot application

      DOP directs NPPA to refix the ceiling price of Gentamicin based on Abbot application

      Farhat Nasim27 Jan 2019 10:00 AM IST
      Abbott demanded to correct the anomaly of Gentamicin Injection 40mg/ml 2ml pack by fixing Ceiling Price using the September 2013 data as base data and...
      Biocon Q3 profit zooms twofold to Rs 217 crore

      Biocon Q3 profit zooms twofold to Rs 217 crore

      Farhat Nasim27 Jan 2019 9:45 AM IST
      Biocon consolidated revenue from operations stood at Rs 1,540.8 crore for the quarter, against Rs 1,057.9 crore, it added. New Delhi: Biotechnology...
      Bar Code to be made mandatory for public procurement of drugs

      Bar Code to be made mandatory for public procurement of drugs

      Farhat Nasim26 Jan 2019 10:00 AM IST
      The medicines procured under Public Procurement from 1st April 2019 must have Bar code /QR Code at primary level packaging. Such Code will mandatorily...
      2019 HITLAB Innovators Summit:  Empowering digital health innovation for over billion lives in India

      2019 HITLAB Innovators Summit: Empowering digital health innovation for over billion lives in India

      Farhat Nasim26 Jan 2019 9:15 AM IST
      The HITLAB Innovators Summit sessions will be presented by leaders from AIIMS, Philips Healthcare, Terumo, Columbia University, ANSYS, NITI Aayog,...
      Natco Pharma ventures into agrichemical space, sets up Rs 100 crore facility in AP

      Natco Pharma ventures into agrichemical space, sets up Rs 100 crore facility in AP

      Farhat Nasim25 Jan 2019 2:30 PM IST
      Natco Pharma Ltd was incorporated in Hyderabad in 1981 with an initial investment of about US$ 54,954.Hyderabad: Nacto Pharma Limited on Friday said...
      DOP directs NPPA to fix retail price of Baclofen Oral Solution based on Sun Pharma Complaint

      DOP directs NPPA to fix retail price of Baclofen Oral Solution based on Sun Pharma Complaint

      Farhat Nasim25 Jan 2019 1:20 PM IST
      New Delhi: Through a recent decision, NPPA has been directed by the Department of Pharmaceuticals to refix the retail price of Baclofen Oral Solution...
      Dr Reddys launches Propofol Injectable Emulsion in US market

      Dr Reddy's launches Propofol Injectable Emulsion in US market

      Farhat Nasim25 Jan 2019 10:58 AM IST
      Propofol Injectable Emulsion is a therapeutic equivalent generic version of Diprivan (Propofol) Injectable Emulsion," the company said in a BSE...
      mfine targets to connect 1000 hospitals,15 cities by next 3 years

      mfine targets to connect 1000 hospitals,15 cities by next 3 years

      Farhat Nasim25 Jan 2019 9:15 AM IST
      mfine also launched the Outpatient Care Program targeted at employees of corporates in Hyderabad; a first in India, Prasad said mfine’s corporate...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok